Wedbush Reiterated an Outperform on Cerulean Pharma (CERU) Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Cerulean Pharma (CERU) Tops Q3 EPS by 2c
November 16, 2015 4:38 PM ESTCerulean Pharma (NASDAQ: CERU) reported Q3 EPS of ($0.39), $0.02 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.
... MoreTrading Radar for 11/16: Agilent (A), Dillard's (DDS), YOU On Demand (YOD), Noah Holdings (NOAH) Report
November 13, 2015 3:09 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
American Electric Technologies (Nasdaq: AETI) - consensus EPS $0.07
Argos Therapeutics (Nasdaq: ARGS) - consensus loss $0.92
Asure Software (Nasdaq: ASUR) - consensus EPS $0.08
BioLineRx (Nasdaq:... More
